Scinai Immunotherapeutics Ltd. (TLV:BVXV)

Scinai Immunotherapeutics Revenue

In the year 2025, Scinai Immunotherapeutics had annual revenue of $1.31M USD with 99.24% growth. Scinai Immunotherapeutics had revenue of $269.00K in the quarter ending December 31, 2025, with 30.58% growth.

• Revenue: $1.31M
• Revenue Growth: +99.24%
• P/S Ratio: 1.73
• Revenue / Employee: $42.29K
• Employees: 31
• Market Cap: 7.25M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.31M	653.00K	99.24%
Dec 31, 2024	658.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 3, 2026

Data Sources Report a data error